 AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 GLOBE NEWSWIRE -- Shattuck Labs, Inc. Shattuck NASDAQ: STTK, a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that Taylor Schreiber, M.D., Ph.D., Chief Executive Officer, and other senior executives will participate in the Cowen 4th Annual IO Next Summit 2020 on November 13, 2020. 